Health Prob Civil.
1. Mohamed YF, Manivannan K, Fernandez RC. Bordetella pertussis. Trends Microbiol. 2023; 31(11): 1192-1193. https://doi.org/10.1016/j.tim.2023.03.012
2.
Mi YM, Deng JK, Zhang T, Cao Q, Wang CQ, Ye S, et al. Expert consensus for pertussis in children: new concepts in diagnosis and treatment. World J Pediatr. 2024; 20(12): 1209-1222. https://doi.org/10.1007/s12519-024-00848-5
3.
Lamond N, Zimmerman L, Wang Y, Maldonado Villeda J, Bjarnason A, Jóhannsdóttir HB, et al. Variation in virulence between three representative Bordetella pertussis pertactin-negative clinical isolates. mSphere. 2025; 10(8): e0031025. https://doi.org/10.1128/msphere.00310-25
4.
Khalil A, Samara A, Campbell H, Ladhani SN, Amirthalingam G. Recent increase in infant pertussis cases in Europe and the critical importance of antenatal immunizations: We must do better…now. Int J Infect Dis. 2024; 146: 107148. https://doi.org/10.1016/j.ijid.2024.107148
5.
Kang HM, Lee TJ, Park SE, Choi SH. Pertussis in the post-COVID-19 era: resurgence, diagnosis, and management. Infect Chemother. 2025; 57(1): 13-30. https://doi.org/10.3947/ic.2024.0117
6.
Yeung KHT, Duclos P, Nelson EAS, Hutubessy RCW. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis. 2017; 17(9): 974-980. https://doi.org/10.1016/s1473-3099(17)30390-0
7.
vaksinite.com [Internet]. Sofia: Vaksinite; 2025. [Immunisation calendar of the Republic of Bulgaria] [access 2025 Jun 17]. Available from: https://www.vaksinite.com/wp-content/uploads/2025/05/imunizatsionen-kalendar-2025.pdf (in Bulgarian).
8.
Kantardzhiev T, Shalamanov D. [The truth about human vaccines]. Sofia: University Press “St. Kliment Ohridski”; 2020 (in Bulgarian).
9.
Kapil P, Wang Y, Zimmerman L, Gaykema M, Merkel TJ. Repeated Bordetella pertussis Infections are required to reprogram acellular pertussis vaccine-primed host responses in the Baboon Model. J Infect Dis. 2024; 229(2): 376-383. https://doi.org/10.1093/infdis/jiad332
10.
Bergquist SO, Bernander S, Dahnsjö H, Sundelöf B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J. 1987; 6(5): 458-461. https://doi.org/10.1097/00006454-198705000-00009
11.
Zeng M, Shao Z, Xia J, Zhang W, Feng T, Cai J, et al. Interpretation of guidelines for diagnosis, management, and prevention of pertussis in China (version 2024). Infect Dis & Immunity. 2025; 5(2): 98-103. https://doi.org/10.1097/ID9.0000000000000141
12.
Ivaska L, Barkoff AM, Mertsola J, He Q. Macrolide resistance in Bordetella pertussis: current situation and future challenges. Antibiotics (Basel). 2022; 11(11): 1570. https://doi.org/10.3390/antibiotics11111570
13.
Hui TY, Luk HK, Choi GK, Chau SK, Tsang LM, Tse CW, et al. Macrolide-resistant Bordetella pertussis in Hong Kong: evidence for post-COVID-19 emergence of ptxP3-lineage MT28 clone from a hospital-based surveillance study. Microorganisms. 2025; 13(8): 1947. https://doi.org/10.3390/microorganisms13081947
14.
Xu Z, Wang Z, Luan Y, Li Y, Liu X, Peng X, et al. Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China. Emerg Microbes Infect. 2019; 8(1): 461-470. https://doi.org/10.1080/22221751.2019.1587315
15.
Suzuki S, Morita Y, Ishige S, Kai K, Kawasaki K, Matsushita K, et al. Effects of quorum sensing-interfering agents, including macrolides and furanone C-30, and an efflux pump inhibitor on nitrosative stress sensitivity in Pseudomonas aeruginosa. Microbiology (Reading). 2024; 170(6): 001464. https://doi.org/10.1099/mic.0.001464
16.
European Centre for Disease Prevention and Control. Increase of pertussis cases in the EU/EEA [Internet]. Stockholm: ECDC; 2024 May 8 [access 2025 Jun 3]. Available from: https://www.ecdc.europa.eu/en/publications-data/increase-pertussis-cases-eueea
17.
Ministry of Health. [Order #1] [Internet]. Sofia: Ministry of Health; 2024 May 8 [access 2024 Sep 21]. Available from: https://www.mh.government.bg/upload/6949/zapoved_rd-01-318_ot_08052024_g.pdf (in Bulgarian).
18.
Ministry of Health. [Order #2] [Internet]. Sofia: Ministry of Health; 2024 July 30 [access 2024 Oct 5]. Available from: https://www.mh.government.bg/upload/11638/Zapoved_merki%20pertussis%20%D0%B0%D0%B2%D0%B3%D1%83%D1%81%D1%82-%D0%B4%D0%B5%D0%BA%D0%B5%D0%BC%D0%B2%D1%80%D0%B8.pdf (in Bulgarian).
19.
Wang Z, Han R, Liu Y, Du Q, Liu J, Ma C, et al. Direct detection of erythromycin-resistant Bordetella pertussis in clinical specimens by PCR. J Clin Microbiol. 2015; 53(11): 3418-3422. https://doi.org/10.1128/JCM.01499-15
20.
National Centre of Infectious and Parasitic Diseases. [Acute infectious diseases in Bulgaria in 2024 (main epidemiological indicators)] [Internet]. Sofia: NCIPD; 2025 [access 2025 May 10] Available from https://ncipd.org/images/Documents/EPI/Analiz_Zarazni_Zabolyavania/Analysis_ZB%20_2024.pdf (in Bulgaria).
21.
Scutari R, Linardos G, Ranno S, Pisani M, Vittucci AN, Coltella L, et al. A new epidemic wave of Bordetella pertussis in paediatric population: impact and role of co-infections in pertussis disease. Ital J Pediatr. 2025; 51(1): 7. https://doi.org/10.1186/s13052-025-01865-4
22.
Hitz DA, Tewald F, Eggers M. Seasonal Bordetella pertussis pattern in the period from 2008 to 2018 in Germany. BMC Infect Dis. 2020; 20(1): 474. https://doi.org/10.1186/s12879-020-05199-w
23.
Pham NT, Bui QT, Tran DM, Larsson M, Pham MP, Olson L. Pertussis seasonal variation in Northern Vietnam: the evidence from a tertiary hospital. BMC Public Health. 2024; 24(1): 286. https://doi.org/10.1186/s12889-024-17705-9
24.
Anderson RM, Grenfell BT, May RM. Oscillatory fluctuations in the incidence of infectious disease and the impact of vaccination: time series analysis. J Hyg (Lond). 1984; 93(3): 587-608. https://doi.org/10.1017/s0022172400065177
25.
ECDC. Pertussis – annual epidemiological report of 2022 [Internet]. Stockholm: ECDC; 2024 Apr 12 [access 2025 Apr 19]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/PERT_AER_2022_Report.pdf
26.
ECDC. Scientific panel on childhood immunisation schedule: Diphtheria-tetanus-pertussis (DTP) vaccination [Internet]. Stockholm: ECDC; 2009 [access 2025 Jul 6]. Available from: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/0911_GUI_Scientific_Panel_on_Childhood_Immunisation_DTP.pdf
27.
CDC. Pertussis vaccination recommendations [Internet]. Atlanta: CDC; 2024 Oct 31 [access 2025 Feb 24]. Available from https://www.cdc.gov/pertussis/hcp/vaccine-recommendations/index.html
28.
Lewis K, Saubolle MA, Tenover FC, Rudinsky MF, Barbour SD, Cherry JD. Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J. 1995; 14(5): 388-391. https://doi.org/10.1097/00006454-199505000-00010
29.
Zhang Q, Li M, Wang L, Xin T, He Q. High-resolution melting analysis for the detection of two erythromycin-resistant Bordetella pertussis strains carried by healthy schoolchildren in China. Clin Microbiol Infect. 2013; 19(6): E260-262. https://doi.org/10.1111/1469-0691.12161
30.
Fu P, Zhou J, Yang C, Nijiati Y, Zhou L, Yan G, et al. Molecular evolution and increasing macrolide resistance of Bordetella pertussis, Shanghai, China, 2016-2022. Emerg Infect Dis. 2023; 30(1): 29-38. https://doi.org/10.3201/eid3001.221588
31.
Zhu X, Wang Z. Resurgence of pertussis in China: Evaluating the efficacy of sulfamethoxazole-trimethoprim as an alternative treatment. J Infect. 2025; 90(1): 106373. https://doi.org/10.1016/j.jinf.2024.106373
32.
Guillot S, Descours G, Gillet Y, Etienne J, Floret D, Guiso N. Macrolide-resistant Bordetella pertussis infection in newborn girl, France. Emerg Infect Dis. 2012; 18(6): 966-968. https://doi.org/10.3201/eid1806.120091
Copyright: © 2025 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
